PGGM Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $121M | Buy |
131,807
+4,868
| +4% | +$4.94M | 2.13% | 15 |
|
|
2025
Q4 | $136M | Buy |
126,939
+30,170
| +31% | +$28.8M | 2.16% | 17 |
|
|
2025
Q3 | $73.8M | Hold |
96,769
| – | – | 1.19% | 35 |
|
|
2025
Q2 | $75.4M | Buy |
96,769
+80,035
| +478% | +$62.2M | 1.31% | 32 |
|
|
2025
Q1 | $13.8M | Buy |
16,734
+3,331
| +25% | +$2.77M | 0.19% | 109 |
|
|
2024
Q4 | $10.3M | Sell |
13,403
-10,202
| -43% | -$8.45M | 0.14% | 129 |
|
|
2024
Q3 | $20.9M | Buy |
+23,605
| New | +$21.2M | 0.27% | 68 |
|
|
2023
Q4 | – | Sell |
-18,615
| Closed | -$10M | – | 357 |
|
|
2023
Q3 | $10M | Sell |
18,615
-17,037
| -48% | -$8.78M | 0.17% | 119 |
|
|
2023
Q2 | $16.7M | Sell |
35,652
-1,972
| -5% | -$827K | 0.27% | 75 |
|
|
2023
Q1 | $12.9M | Buy |
37,624
+9,892
| +36% | +$3.34M | 0.22% | 83 |
|
|
2022
Q4 | $10.1M | Sell |
27,732
-27,610
| -50% | -$9.79M | 0.18% | 113 |
|
|
2022
Q3 | $17.9M | Buy |
+55,342
| New | +$17.5M | 0.31% | 63 |
|
|
2022
Q1 | $54.4M | Hold |
196,777
| – | – | 0.27% | 83 |
|
|
2021
Q4 | $54.4M | Sell |
196,777
-16,813
| -8% | -$4.26M | 0.27% | 83 |
|
|
2021
Q3 | $49.4M | Sell |
213,590
-19,336
| -8% | -$4.77M | 0.25% | 98 |
|
|
2021
Q2 | $53.5M | Sell |
232,926
-70,931
| -23% | -$14.2M | 0.23% | 92 |
|
|
2021
Q1 | $56.8M | Sell |
303,857
-148,051
| -33% | -$29M | 0.25% | 87 |
|
|
2020
Q4 | $76.3M | Sell |
451,908
-235,601
| -34% | -$35.2M | 0.35% | 60 |
|
|
2020
Q3 | $102M | Buy |
687,509
+56,948
| +9% | +$8.81M | 0.53% | 55 |
|
|
2020
Q2 | $104M | Buy |
630,561
+81,403
| +15% | +$12.5M | 0.6% | 55 |
|
|
2020
Q1 | $76.2M | Buy |
549,158
+4,143
| +0.8% | +$569K | 0.55% | 56 |
|
|
2019
Q4 | $71.6M | Buy |
545,015
+510,751
| +1,491% | +$59.2M | 0.4% | 60 |
|
|
2019
Q3 | $3.83M | Hold |
34,264
| – | – | 0.02% | 226 |
|
|
2019
Q2 | $3.8M | Hold |
34,264
| – | – | 0.02% | 229 |
|
|
2019
Q1 | $4.45M | Sell |
34,264
-5,392
| -14% | -$656K | 0.02% | 236 |
|
|
2018
Q4 | $4.59M | Hold |
39,656
| – | – | 0.03% | 244 |
|
|
2018
Q3 | $4.25M | Hold |
39,656
| – | – | 0.02% | 256 |
|
|
2018
Q2 | $3.38M | Buy |
+39,656
| New | +$3.26M | 0.02% | 261 |
|
|
2017
Q4 | – | Sell |
-802,016
| Closed | -$68.6M | – | 346 |
|
|
2017
Q3 | $68.6M | Sell |
802,016
-31,249
| -4% | -$2.56M | 0.34% | 76 |
|
|
2017
Q2 | $68.6M | Sell |
833,265
-12,617
| -1% | -$1.03M | 0.35% | 67 |
|
|
2017
Q1 | $71.1M | Sell |
845,882
-46,770
| -5% | -$3.75M | 0.37% | 65 |
|
|
2016
Q4 | $65.7M | Buy |
892,652
+1,746
| +0.2% | +$130K | 0.34% | 68 |
|
|
2016
Q3 | $71.5M | Buy |
890,906
+39,938
| +5% | +$3.2M | 0.36% | 61 |
|
|
2016
Q2 | $67M | Buy |
850,968
+502
| +0.1% | +$37.8K | 0.34% | 69 |
|
|
2016
Q1 | $61.2M | Buy |
850,466
+41,250
| +5% | +$3.12M | 0.32% | 70 |
|
|
2015
Q4 | $68.2M | Sell |
809,216
-18,114
| -2% | -$1.5M | 0.36% | 69 |
|
|
2015
Q3 | $69.2M | Sell |
827,330
-11,501
| -1% | -$971K | 0.37% | 68 |
|
|
2015
Q2 | $70M | Sell |
838,831
-435,530
| -34% | -$33.2M | 0.36% | 67 |
|
|
2015
Q1 | $92.6M | Buy |
1,274,361
+847,839
| +199% | +$60.4M | 0.44% | 59 |
|
|
2014
Q4 | $29.4M | Hold |
426,522
| – | – | 0.13% | 180 |
|
|
2014
Q3 | $27.7M | Buy |
426,522
+20,790
| +5% | +$1.32M | 0.13% | 178 |
|
|
2014
Q2 | $25.2M | Buy |
405,732
+19,661
| +5% | +$1.17M | 0.12% | 204 |
|
|
2014
Q1 | $22.7M | Sell |
386,071
-337,759
| -47% | -$18.8M | 0.12% | 221 |
|
|
2013
Q4 | $36.9M | Sell |
723,830
-10,118
| -1% | -$507K | 0.2% | 154 |
|
|
2013
Q3 | $36.9M | Sell |
733,948
-860,696
| -54% | -$45.1M | 0.22% | 151 |
|
|
2013
Q2 | $78.3M | Buy |
+1,594,644
| New | +$86.8M | 0.46% | 56 |
|
Other funds holding LLY
VCM
VPM
PGGM Investments's LLY Position: Q1 2026 in Review
PGGM Investments increased its Eli Lilly (LLY) stake by 3.8% in Q1 2026, buying an estimated $4.94M and bringing the position to 131,807 shares worth $121M. The position accounts for 2.13% of the portfolio, ranked #15.
PGGM Investments first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. The position peaked at $136M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- PGGM Investments held 131,807 shares of Eli Lilly worth $121M as of Q1 2026.
- PGGM Investments bought 4,868 Eli Lilly shares in Q1 2026, an estimated $4.94M.
- Eli Lilly made up 2.13% of PGGM Investments's portfolio in Q1 2026, its #15 holding.
- PGGM Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
- PGGM Investments's Eli Lilly position peaked at $136M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on PGGM Investments's 13F filing for Q1 2026, filed 15 May 2026.